Patents by Inventor Emre Cebeci

Emre Cebeci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular basis of fatty liver inhibition by sodium borates
    Patent number: 12521413
    Abstract: Sodium borates are provided as the sole active ingredient to prevent and/or treat fatty liver. In addition, the sodium borates reduce the expression levels of ADIPOR2, PRKAG2, IRS1, PIK3R1, NFKB1, MAP3K11, BID, CYCS, BAX, CASP3 and TGFB1 genes in the non-alcoholic fatty liver pathway and thereby to prevent and/or treat fatty liver by inhibiting the functioning of the non-alcoholic fatty liver pathway.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: January 13, 2026
    Assignee: YEDITEPE UNIVERSITESI
    Inventors: Fikrettin Sahin, Emre Cebeci, Huseyin Abdik
  • MOLECULAR BASIS OF FATTY LIVER INHIBITION BY SODIUM BORATES
    Publication number: 20240000831
    Abstract: sodium borates are provided and alone as an active ingredient to prevent and/or treat fatty liver. In addition, the sodium borates reduce the expression levels of AADIPOR2, PRKAG2, IRS1, PIK3R1, NFKB1, MAP3K11, BID, CYCS, BAX, CASP3 and TGFB1 genes in the non-alcoholic fatty liver pathway and thereby to prevent and/or treat fatty liver by inhibiting the functioning of the non-alcoholic fatty liver pathway.
    Type: Application
    Filed: November 25, 2020
    Publication date: January 4, 2024
    Applicant: YEDITEPE UNIVERSITESI
    Inventors: Fikrettin SAHIN, Emre CEBECI, Huseyin ABDIK
  • ANTI-CANCER ACTIVITY OF PERBORATE SALTS
    Publication number: 20230263825
    Abstract: The disclosure is directed to perborate salts, such as sodium perborate tetrahydrate, and their uses as anticancer agents. The disclosure is also directed to pharmaceutical compositions comprising perborate salts. The disclosure is also directed to methods for suppressing or reducing expression of one or more gene in a cancer cell or a tumor cell.
    Type: Application
    Filed: July 7, 2021
    Publication date: August 24, 2023
    Inventors: Altay Burak Dalan, Fikrettin Sahin, Emre Cebeci, Ömer Faruk Bayrak